title: [The role of telomerase activity in non-invasive diagnostics of bladder cancer].
abstract: OBJECTIVE
  To evaluate the potentials of determining the telomerase activity (TA) in the cellular material of the urine for noninvasive diagnosis of bladder cancer (BC).
  
  
  METHODS
  Evaluation of TA was performed in the urine of 48 patients with bladder cancer (study group) before and after transurethral resection of the bladder wall (n=38), an open resection of the bladder (n=4), and cystectomy (n=6). TA was also evaluated in 48 tumor tissue samples obtained from these patients during removal of the bladder tumor. Each sample of the tumor tissue was separated into two parts, one of which was subjected to histological examination, and the latter was used to determine the telomerase activity. In all cases, the diagnosis of bladder cancer was confirmed morphologically. Determination of TA in the samples was performed by the modified TRAP-method (telomerase repeat amplification protocol), RT-PCR, PCR, and electrophoresis. As a control, cell material of the urine and tissue in 12 patients with chronic cystitis was investigated.
  
  
  RESULTS
  TA before surgery was found in 45 (93.75%) of 48 samples of cellular material of the urine from patients with suspected bladder cancer. BC was histologically verified in all patients in this group. In the postoperative period, TA was not observed in the 48 samples of cellular material of the urine from patients with BC. In the control group of patients with histologically verified cystitis, weak TA was determined only in one sample of cellular material of the urine. The analysis indicates statistically significant predominance of patients with bladder cancer in case of TA in the urine (P=0.001). TA was detected in all samples of tumor tissue. We also analyzed the dependence of TA levels in urine and tissue on the degree of BC differentiation. In patients with highly differentiated BC, mean AT in the cellular materials of the urine was 0,61% (n=15), in patients with moderately differentiated BC - 0.95% (n=23), in patients with low-grade bladder cancer - 1.33% (n=10); in other words, increase in the TA levels with decreasing the degree of differentiation was observed. This finding can be used in the prognosis of the course of disease based on determining the TA level in these patients.
  
  
  CONCLUSIONS
  Preliminary data indicate the possibility of use of determining the TA in cellular material of the urine for the diagnosis and monitoring of bladder cancer recurrence.
authors.affiliation: I.M. Sechenov First Moscow State Medical University, Research Institute for Uronephrology.
authors.forename: P V
authors.initials: PV
authors.lastname: Glybochko
authors.affiliation: I.M. Sechenov First Moscow State Medical University, Research Institute for Uronephrology.
authors.forename: J G
authors.initials: JG
authors.lastname: Alyaev
authors.affiliation: I.M. Sechenov First Moscow State Medical University, Research Institute for Uronephrology.
authors.forename: N V
authors.initials: NV
authors.lastname: Potoldykova
authors.affiliation: I.M. Sechenov First Moscow State Medical University, Research Institute for Uronephrology.
authors.forename: K A
authors.initials: KA
authors.lastname: Polyakovsky
authors.affiliation: I.M. Sechenov First Moscow State Medical University, Research Institute for Uronephrology.
authors.forename: A Z
authors.initials: AZ
authors.lastname: Vinarov
authors.affiliation: I.M. Sechenov First Moscow State Medical University, Department of Biochemistry.
authors.forename: A I
authors.initials: AI
authors.lastname: Glukhov
authors.affiliation: I.M. Sechenov First Moscow State Medical University, Department of Biochemistry.
authors.forename: S A
authors.initials: SA
authors.lastname: Gordeev
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000652:urine*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012372:ROC Curve; D019098:Telomerase / Q000378:metabolism*; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis* / Q000201:enzymology / Q000473:pathology / Q000652:urine; D014556:Urine / Q000166:cytology
chemical_list: D014408:Biomarkers, Tumor; D019098:Telomerase
keywords: PCR; RT-PCR; amplification products of telomerase reaction; bladder cancer; electrophoresis; telomerase; telomerase activity